Literature DB >> 23089829

[Non-pharmacological and pharmacological treatment of arterial hypertension: current situation].

J Hoyer1.   

Abstract

A permanent and successful treatment of high blood pressure is based on a combination of non-pharmacological treatment measures and pharmacological therapy. The most proven non-pharmacological measures are physical and sports activities, weight reduction, dietary adaption and reduction of salt intake as well as nicotine abstinence and moderate alcohol consumption. A blood pressure reducing effect of evidence grade A was demonstrated for these 4 pillars of non-pharmacological therapy in studies. For pharmacological treatment five main substance groups are available: thiazide diuretics, ACE inhibitors, AT1 blockers, calcium channel blockers and beta blockers. A very good blood pressure reducing effect with an advantageous side effect profile has been proven for all substances. The initial high blood pressure therapy can be carried out with monotherapy but therapy with several antihypertensives is often necessary for the very varied combination of compounds which are available in a meaningful combination and dosage of effective ingredients. For the treatment of comorbid hypertensive patients recommendations are available for an individualized pharmacological treatment corresponding to the specific cardiovascular risk and comorbidity. High blood pressure therapy must be continuously carried out over many years. For permanent success of the therapy good compliance is indispensible which can be encouraged by integration in the therapy and should be regularly controlled.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089829     DOI: 10.1007/s00059-012-3691-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  24 in total

Review 1.  Salt restriction for the prevention of cardiovascular disease.

Authors:  Dieter Klaus; Joachim Hoyer; Martin Middeke
Journal:  Dtsch Arztebl Int       Date:  2010-07-02       Impact factor: 5.594

Review 2.  Role of dietary therapies in the prevention and treatment of hypertension.

Authors:  Viresh Mohanlal; Afshin Parsa; Matthew R Weir
Journal:  Nat Rev Nephrol       Date:  2012-05-15       Impact factor: 28.314

3.  The "Million Hearts" initiative--preventing heart attacks and strokes.

Authors:  Thomas R Frieden; Donald M Berwick
Journal:  N Engl J Med       Date:  2011-09-13       Impact factor: 91.245

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

Review 5.  Beta-blockers for hypertension.

Authors:  Charles Shey Wiysonge; Hazel A Bradley; Jimmy Volmink; Bongani M Mayosi; Anthony Mbewu; Lionel H Opie
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 7.  Diabetes and hypertension: the bad companions.

Authors:  Ele Ferrannini; William C Cushman
Journal:  Lancet       Date:  2012-08-11       Impact factor: 79.321

8.  Drug of choice in the management of hypertension in diabetes and diabetic nephropathy: angiotensin-converting enzyme inhibitors.

Authors:  Eberhard Ritz
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04       Impact factor: 3.738

9.  National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.

Authors:  George Bakris; Joseph Vassalotti; Eberhard Ritz; Christoph Wanner; George Stergiou; Mark Molitch; Richard Nesto; George A Kaysen; James R Sowers
Journal:  Kidney Int       Date:  2010-08-18       Impact factor: 10.612

10.  Association between smoking and blood pressure: evidence from the health survey for England.

Authors:  P Primatesta; E Falaschetti; S Gupta; M G Marmot; N R Poulter
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.